Blood pressure responses of endothelin-11-31 within the rostral ventrolateral medulla through conversion to endothelin-11-21

Journal of Cardiovascular Pharmacology

Volumn 46, Issue 6, 2005, Pages 823-829

  Lu, Yan ^a   Wang, Wei Zhong ^a   Liao, Zhuan ^b   Yan, Xiao Hong ^a   Tang, Chao Shu ^c   Yuan, Wen Jun ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY   (China)

Author keywords

Blood pressure; Endothelin 11 31; ET converting enzyme; ET receptors; Microinjection; Rostral ventrolateral medulla

Indexed keywords

AMINO ACID; CHYMASE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN 1 [1-21]; ENDOTHELIN 1 [1-31]; ENDOTHELIN 1 [11-21]; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN CONVERTING ENZYME INHIBITOR; ENDOTHELIN RECEPTOR; PHOSPHORAMIDON; UNCLASSIFIED DRUG; CYCLO(TRP ASP PRO VAL LEU); CYCLO(TRP-ASP-PRO-VAL-LEU); CYCLOPEPTIDE; DRUG DERIVATIVE; ENDOTHELIN 1 (1 21); ENDOTHELIN 1 (1 31); ENDOTHELIN A RECEPTOR; ENDOTHELIN-1 (1-21); ENDOTHELIN-1 (1-31); GLYCOPEPTIDE; PEPTIDE FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; BRAIN REGION; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG RECEPTOR BINDING; MALE; MICROINJECTION; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN HYDROLYSIS; RAT; ROSTRAL VENTROLATERAL MEDULLA; ANIMAL; DRUG EFFECT; HEART RATE; MEDULLA OBLONGATA; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD PRESSURE; ENDOTHELIN-1; GLYCOPEPTIDES; HEART RATE; MALE; MEDULLA OBLONGATA; PEPTIDE FRAGMENTS; PEPTIDES, CYCLIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A;

EID: 33644682670     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000188884.28177.eb     Document Type: Article

References (36)

1. Nunez DJ, Brown MJ, Davenport AP, et al. Endothelin-1 mRNA is widely expressed in porcine and human tissues. J Clin Invest. 1990;85:1537-1541.
2. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
3. Nakano A, Kishi F, Minami K, et al. Selective conversion of big endothelins to tracheal smooth muscle-constricting 31-amino acid-length endothelins by chymase from human mast cells. J Immunol. 1997;159:1987-1992.
4. Leslie SJ, Rahman MQ, Denvir MA, et al. Endothelins and their inhibition in the human skin microcirculation: ET[1-31], a new vasoconstrictor peptide. Br J Clin Pharmacol. 2004;57:720-725.
5. Rossi GP, Andreis PG, Colonna S, et al. Endothelin-1[1-31]: a novel autocrine-paracrine regulator of human adrenal cortex secretion and growth. J Clin Endocrinol Metab. 2002;87:322-328.
6. Hanson GC, Andersson KE, Gyllstedt E, et al. Hydrolysis of big endothelin-1 by a serine protease in the membrane fraction of human lung. Regul Pept. 1997;68:63-69.
7. Goldie RG, D'Aprile AC, Self GJ, et al. Influence of endothelin-1(1-31) on smooth muscle tone and cholinergic nerve-mediated contraction in rat isolated trachea. J Cardiovasc Pharmacol Suppl. 2000;36:S228-S231.
8. Kido H, Nakano A, Okishima N, et al. Human chymase, an enzyme forming novel bioactive 31-amino acid length endothelins. Biol Chem. 1998;379:885-891.
9. Yoshizumi M, Kim S, Kagami S, et al. Effect of endothelin-1 (1-31) on extracellular signal-regulated kinase and proliferation of human coronary artery smooth muscle cells. Br J Pharmacol. 1998;125:1019-1027.
10. Kuwaki T, Ling GY, Onodera M, et al. Endothelin in the central control of cardiovascular and respiratory functions. Clin Exp Pharmacol Physiol. 1999;26:989-994.
11. Rubanyi GM, Botelho LH. Endothelins. FASEBJ. 1991;5:2713-2720.
12. Dampney RA. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev. 1994;74:323-364.
13. Koseki C, Imai M, Hirata Y, et al. Binding sites for endothelin-1 in rat tissues: an autoradiographic study. J Cardiovasc Pharmacol Suppl. 1989;135:S153-S154.
14. Mosqueda-Garcia R, Yates K, O'Leary J, et al. Cardiovascular and respiratory effects of endothelin in the ventrolateral medulla of the normotensive rat. Hypertension. 1995;26:263-271.
15. Kumar A, Shahani BT, Gulati A. Modification of systemic and regional circulatory effects of intracerebroventricular administration of endothelin-1 by propranolol in anesthetized rats. Gen Pharmacol. 1996;27:1025-1033.
16. Nagasaka J, Tsuji M, Takeda H, et al. Role of endothelin receptor subtypes in the behavioral effects of the intracerebroventricular administration of endothelin-1 in conscious rats. Pharmacol Biochem Behav. 1999;64:171-176.
17. Baltatu O, Nishimura H, Hoffmann S, et al. High levels of human chymase expression in the pineal and pituitary glands. Brain Res. 1997;752:269-278.
18. Masliniska D, Dambska M, Kaliszek A, et al. Accumulation, distribution and phenotype heterogeneity of mast cells (MC) in human brains with neurocysticercosis. Folia Neuropathol. 2001;39:7-13.
19. Wang WZ, Yuan WJ, Tang CS, et al. Electrophysiological evidences for the contribution of NMDA receptors to the inhibition of clonidine on the RVLM presympathetic neurons. Brain Res. 2004;1023:163-166.
20. Wang WZ, Yuan WJ, Su DF. Blockade of N-methyl-D-aspartate receptors within the rostral ventrolateral medulla antagonizes clonidine-induced cardiovascular effects. Auton Neurosci. 2003;109:21-28.
21. Mosqueda-Garcia R, Inagami T, Appalsamy M, et al. Endothelin as a neuropeptide. Cardiovascular effects in the brainstem of normotensive rats. Circ Res. 1993;72:20-35.
22. Gulati A, Kumar A, Shahani BT. Cardiovascular effects of centrally administered endothelin-1 and its relationship to changes in cerebral blood flow. Life Sci. 1996;58:437-445.
23. Yoshizumi M, Inui D, Okishima N, et al. Endothelin-1-(1-31), a novel vasoactive peptide, increases [Ca2+]i in human coronary artery smooth muscle cells. Eur J Pharmacol. 1998;348:305-309.
24. Hayasaki-Kajiwara Y, Naya N, Shimamura T, et al. Endothelin generating pathway through endothelin1-31 in human cultured bronchial smooth muscle cells. Br J Pharmacol. 1999;127:1415-1421.
25. Kuwaki T, Koshiya N, Takahashi H, et al. Modulatory effects of rat endothelin on central cardiovascular control in rats. Jpn J Physiol. 1990;40:97-116.
26. Siddall PJ, Polson JW, Dampney RA. Descending antinociceptive pathway from the rostral ventrolateral medulla: a correlative anatomical and physiological study. Brain Res. 1994;645:61-68.
27. Nakamura K, Sasaki S, Moriguchi J, et al. Central effects of endothelin and its antagonists on sympathetic and cardiovascular regulation in SHRSP. J Cardiovasc Pharmacol. 1999;33:876-882.
28. Kumada M, Cao W, Kuwaki T. Effect of endothelin on vasomotor and respiratory neurons in the rostral ventrolateral medulla in rats. Cell Mol Neurobiol. 2003;23:691-707.
29. Cao WH, Kuwaki T, Unekawa M, et al. Action of endothelin-1 on vasomotor neurons in rat rostral ventrolateral medulla. J Cardiovasc Pharmacol Suppl. 1993;22:S196-S198.
30. Anggard EE, Botting RM, Vane JR. Endothelins. BloodVessels. 1990;27:269-281.
31. Gross PM, Zochodne DW, Wainman DS, et al. Intraventricular endothelin-1 uncouples the blood flow: metabolism relationship in periventricular structures of the rat brain: involvement of L-type calcium channels. Neuropeptides. 1992;22:155-165.
32. Gulati A, Rebello S, Kumar A. Role of sympathetic nervous system in cardiovascular effects of centrally administered endothelin-1 in rats. Am J Physiol. 1997;273:H1177-H1186.
33. Chew BH, Weaver DF, Gross PM. Dose-related potent brain stimulation by the neuropeptide endothelin-1 after intraventricular administration in conscious rats. Pharmacol Biochem Behav. 1995;51:37-47.
34. Ouchi Y, Kim S, Souza AC, et al. Central effect of endothelin on blood pressure in conscious rats. Am J Physiol. 1989;256:H1747-H1751.
35. Van den Buuse M, Webber KM. Endothelin and dopamine release. Prog Neurobiol. 2000;60:385-405.
36. Rossi NF. Regulation of vasopressin secretion by ETA and ETB receptors in compartmentalized rat hypothalamo-neurohypophysial explants. Am J Physiol Endocrinol Metab. 2004;286:E535-E541.